Identification of an Autophagy Defect in Smokers’ Alveolar Macrophages
Author(s) -
Martha M. Monick,
Linda S. Powers,
Katherine S. Walters,
Nina Lovan,
Michael S. Zhang,
Alicia K. Gerke,
Sif Hansdóttir,
Gary W. Hunninghake
Publication year - 2010
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1001603
Subject(s) - autophagy , alveolar macrophage , lung , immune system , alveolar cells , mitochondrion , microbiology and biotechnology , immunology , inflammation , biology , macrophage , medicine , chemistry , apoptosis , in vitro , biochemistry
Alveolar macrophages are essential for clearing bacteria from the alveolar surface and preventing microbe-induced infections. It is well documented that smokers have an increased incidence of infections, in particular lung infections. Alveolar macrophages accumulate in smokers' lungs, but they have a functional immune deficit. In this study, we identify an autophagy defect in smokers' alveolar macrophages. Smokers' alveolar macrophages accumulate both autophagosomes and p62, a marker of autophagic flux. The decrease in the process of autophagy leads to impaired protein aggregate clearance, dysfunctional mitochondria, and defective delivery of bacteria to lysosomes. This study identifies the autophagy pathway as a potential target for interventions designed to decrease infection rates in smokers and possibly in individuals with high environmental particulate exposure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom